These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 27243229)

  • 1. Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria.
    Choi WS; Lim ES; Ban GY; Kim JH; Shin YS; Park HS; Ye YM
    Korean J Intern Med; 2018 Jan; 33(1):185-192. PubMed ID: 27243229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to assess disease activity in patients with chronic urticaria?
    Młynek A; Zalewska-Janowska A; Martus P; Staubach P; Zuberbier T; Maurer M
    Allergy; 2008 Jun; 63(6):777-80. PubMed ID: 18445192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of the computerized chronic urticaria-specific quality of life questionnaire in Korean patients with chronic urticaria.
    Ye YM; Park JW; Kim SH; Choi JH; Hur GY; Lee HY; Lee EH; Park HS
    Clin Exp Dermatol; 2012 Oct; 37(7):722-8. PubMed ID: 22731761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic urticaria in Chinese population: a hospital-based multicenter epidemiological study.
    Zhong H; Song Z; Chen W; Li H; He L; Gao T; Fang H; Guo Z; Xv J; Yu B; Gao X; Xie H; Gu H; Luo D; Chen X; Lei T; Gu J; Cheng B; Duan Y; Xv A; Zhu X; Hao F
    Allergy; 2014 Mar; 69(3):359-64. PubMed ID: 24354882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study).
    Lacour JP; Khemis A; Giordano-Labadie F; Martin L; Staumont-Salle D; Hacard F; Tian H; McBride D; Hollis K; Hunter S; Martin L; Lamirand A; Le Guen S; Balp MM; Berard F
    Eur J Dermatol; 2018 Dec; 28(6):795-802. PubMed ID: 30698148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
    Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Canvin J; Maurer M
    Allergy; 2016 Aug; 71(8):1135-44. PubMed ID: 27010957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity.
    Staubach P; Eckhardt-Henn A; Dechene M; Vonend A; Metz M; Magerl M; Breuer P; Maurer M
    Br J Dermatol; 2006 Feb; 154(2):294-8. PubMed ID: 16433799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in the quality of life of patients with chronic spontaneous urticaria treated with omalizumab in real life.
    Larrea-Baca I; Gurpegui-Resano M
    Enferm Clin; 2017; 27(6):361-368. PubMed ID: 28457893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Headache deteriorates the quality of life in children with chronic spontaneous urticaria.
    Filiz S; Kutluk MG; Uygun DFK
    Allergol Immunopathol (Madr); 2019; 47(3):254-259. PubMed ID: 30686612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
    Maurer M; Staubach P; Raap U; Richter-Huhn G; Bauer A; Ruëff F; Jakob T; Yazdi AS; Mahler V; Wagner N; Lippert U; Hillen U; Schwinn A; Pawlak M; Behnke N; Chaouche K; Chapman-Rothe N
    Clin Exp Allergy; 2017 May; 47(5):684-692. PubMed ID: 28160338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study).
    Jauregui I; Gimenez-Arnau A; Bartra J; Labrador-Horrillo M; de Frutos JO; Silvestre JF; Sastre J; Velasco M; Ferrer M; Ballesteros C; Valero A
    Health Qual Life Outcomes; 2019 Jan; 17(1):23. PubMed ID: 30704532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey.
    Büyüköztürk S; Gelincik A; Demirtürk M; Kocaturk E; Colakoğlu B; Dal M
    J Dermatol; 2012 May; 39(5):439-42. PubMed ID: 22221177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE-CSU.
    Sussman G; Abuzakouk M; Bérard F; Canonica W; Oude Elberink H; Giménez-Arnau A; Grattan C; Hollis K; Hunter S; Knulst A; Lacour JP; Lynde C; Marsland A; McBride D; Maurer M; Nakonechna A; Ortiz de Frutos J; Reynolds M; Sweeney C; Tian H; Weller K; Wolin D; Balp MM
    Allergy; 2018 Aug; 73(8):1724-1734. PubMed ID: 29460968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data.
    Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Maurer M; Weller K
    Allergy; 2018 Mar; 73(3):576-584. PubMed ID: 29058822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inducible urticaria and chronic spontaneous urticaria].
    Du Thanh A
    Ann Dermatol Venereol; 2014 Nov; 141 Suppl 3():S570-9. PubMed ID: 25539678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angioedema and urticaria].
    Boccon-Gibod I; Bouillet L
    Ann Dermatol Venereol; 2014 Nov; 141 Suppl 3():S586-95. PubMed ID: 25539680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema.
    Maurer M; Sofen H; Ortiz B; Kianifard F; Gabriel S; Bernstein JA
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):1056-1063. PubMed ID: 27911016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study.
    Maurer M; Raap U; Staubach P; Richter-Huhn G; Bauer A; Oppel EM; Hillen U; Baeumer D; Reinhardt M; Chapman-Rothe N
    Clin Exp Allergy; 2019 May; 49(5):655-662. PubMed ID: 30415478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in patients with urticaria and angioedema: assessing burden of disease.
    Weldon D
    Allergy Asthma Proc; 2014; 35(1):4-9. PubMed ID: 24433591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data.
    Salman A; Demir G; Bekiroglu N
    Dermatol Ther; 2019 Jul; 32(4):e12975. PubMed ID: 31145524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.